Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they had initiated a ARTI-19 randomized, controlled, multi-site India…
Cocrystal Pharma announced publication of positive data demonstrating potent in vitro inhibition against Coronavirus
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
Atossa Therapeutics received approval to open clinical study of AT-301 nasal spray being developed to treat COVID-19
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
CDC | HIV | Therapeutics
CDC awarded $109 million to local areas and states for initiative to end the HIV epidemic in the U.S.
On Jul. 31, 2020, the Centers for Disease Control and Prevention (CDC) awarded $109 million to state and…
Researchers reported fat-based molecules key to Zika virus infection
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
NIH-funded project created an encyclopedia detailing the inner workings of the human and mouse genomes
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax program (heat stable COVID-19…
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
Biotechnology | COVID-19 | NIH | Therapeutics
National Institutes of Health selected Humanigen’s lenzilumab for its COVID-19 Big Effect Trial
On Jul. 27, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases and Humanigen had…
Immunic announced first patients enrolled in investigator-sponsored phase 2 clinical trial of IMU-838 in combination with Oseltamivir for treatment of patients with COVID-19
On Jul. 27, 2020, Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial…
Biotechnology | COVID-19 | NIH | Therapeutics
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
Biotechnology | COVID-19 | FDA | Medicine | Therapeutics | Vaccine
Medigen Vaccines collaborated with Dynavax to develop novel adjuvanted COVID-19 vaccine candidate
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics (MVC) announced a collaboration to develop an adjuvanted…
Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19
On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…
Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines
On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…
RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…
Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
Broad Institute launched academic-industry cell imaging consortium to speed drug discovery and development
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
UT Southwestern, Texas Health launched collaborative study to better understand COVID prevalence in DFW
On Jul. 10, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced that they will…
ViralClear partnered with Albany Molecular on manufacture of merimepodib API development for potential treatment of COVID-19
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
Moderna and ROVI announced collaboration for OUS fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
NIH launched clinical trials network to test COVID-19 vaccines and other prevention tools
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
Biotechnology | COVID-19 | Disease | Therapeutics | WHO
Access to HIV medicines severely impacted by COVID-19 as AIDS response stalled
On Jul. 8, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…